/home/ejo ORIGINAL RESEARCH ARTICLE tion, vitreoretinal traction, persistent cystoid macular edema (CME), macular hole formation, and traction detachment.
Introduction
Intermediate uveitis (IU) induces changes in the hematoocular barrier, structural changes at the base of Müller cells within the retina, surface retinal changes, and vitreal pathologic changes. Appointed complications in the posterior segment of the eye and the side effects of medical treatment are among the most important factors in the formation of amblyopia in the developing child's eye. Pars plana vitrectomy (PPV) is a safe procedure in the treatment of IU in children (1) . Pars plana vitrectomy in IU is indicated as either a diagnostic procedure, especially in the differential diagnosis of malignancy, or as a therapeutic procedure. Proper timing of PPV helps to decrease sight-threatening complications such as vitreous haemorrhage and opacities, epiretinal membrane forma-
The children chosen for our study were younger than 13 at the time of PPV. They had been diagnosed with chronic, refractory IU associated with a decrease in VA to 0.5 or worse despite corticosteroid treatment, cryopexy, and/or laser photocoagulation of the retinal periphery. One eye was operated on for a complicated cataract before PPV. Children whose decrease in VA was due to cataracts were excluded. Uveitic entities such as peripheral toxoplasmosis, toxocariasis, tuberculosis, syphilis, sarcoidosis, Lyme disease, cat-scratch disease, and viral infection were ruled out before starting therapy. Children underwent history, systemic (complete blood and serologic testing, chest X-ray, skin testing, spirometry, abdominal ultrasound, and neurologic history with a spinal tap in indicated cases), and ocular examination by means of standard procedures (best-corrected Snellen VA, slit-lamp biomicroscopy, ophthalmoscopy, and tonometry).
Treatment of IU before surgery included the initial step of corticosteroids given locally and periocularly, followed by oral and IV corticosteroid therapy. The present study did not include children treated with immunomodulatory therapy. Cryopexy or laser photocoagulation of the retinal periphery were employed next. Finally, PPV was instituted for refractory IU. Our indication for PPV was if children developed persistent CME, vitreous dense floaters and debris to the point where only major retinal vessels were seen, or epiretinal membrane formation. Before surgery, all children had had a history of at least 2 episodes of acute IU despite treatment.
Surgery was performed by the same surgeon after the onset of a new active outbreak. Surgery consisted of a 20-G PPV under general anesthetic. Pars plana vitrectomy was initiated by vitreous sampling for laboratory examination. A volume of 0.5-1.5 mL of undiluted vitreous was obtained from all vitrectomized eyes. Vitreous specimens were analyzed by cytologic and histopathologic examination, microbiologic culture, and polymerase chain reaction. Pars plana vitrectomy was always completed with posterior vitreous detachment, the preparation of pathologic vitreoretinal adhesions in all eyes, and cerclage in 5 eyes to decrease postoperative vitreoretinal traction. In 2 cases, 4 mg of triamcinolone acetonide were applied perioperatively to make the posterior hyaloid cortex more visible. After the conjunctiva was sutured, paraocular gentamicin and dexamethasone were injected.
Data recorded were evaluated before initiation of vitrectomy and afterward for a median observation period of up to 10.3 years. These data included Snellen VA, intraocular pressure (IOP) by applanation tonometry, cataract formation, anterior chamber and vitreous cellular activity, perioperative or postoperative PPV complications, and presence of CME. To confirm CME, optical coherence tomography (OCT) or fluorescein angiography was performed.
Results
A retrospective study has evaluated the results of PPV indicated for IU with a minimum observation period of 7 years (mean observation period 10.3 years, range 7-15.6 years) in 6 children (mean age 8 years, range 6-12 years). We evaluated 10 eyes overall. Table I summarizes the main characteristics of the group under study.
Cystoid macular edema was diagnosed in 8 eyes from 5 children (bilateral in 3 children-nos. 2, 3, and 6 and unilateral in 2 children -No. 1, 4-and unilateral in 2 children-nos. 2 and 4). Furthermore, dense floaters in the vitreous were present in 1 eye and the epiretinal membrane was scanned by OCT in 4 eyes.
The chronic course of IU caused zonular keratopathy in 4 eyes, retinal neovessels in 4 eyes, and optic nerve head edema in 1 eye. One eye developed secondary glaucoma, probably because of inflammatory activity, which was treated conservatively. One eye had undergone a previous cataract extraction with a posterior chamber intraocular lens implantation completed with peripheral iridectomy 30 months before PPV. The IU was classified as idiopathic in 3 children. One child had IU associated with human leucocyte antigen B5 (no. 4). Two children were positive for immunoglobulin G vitreal toxoplasma antibodies (no. 3 and 5).
Cytologic examination of vitreous samples revealed lymphocytic infiltration, predominantly T cells, of which CD4+, epithelioid cells, and multinucleated giant cells were mostly seen. Other bacteriologic, virologic, mycotic, and cytologic analyses of the vitreous were negative in all tested children.
Preoperatively, 2 eyes developed 2 active attacks of IU, 3 eyes 3 attacks, 3 eyes 4 attacks, 1 eye 5 attacks, and 1 eye 6 attacks despite treatment. Table II lists each child's treatment regimen. All 10 eyes were treated with peripheral cryopexy of the lower peripheral part of the retina. The mean observation period before surgery was 3.7 years (range 8 months-6.8 years). Equatorial cerclage was indicated in 5 eyes at the beginning of PPV to prevent vitreoretinal postoperative traction in the vitreous base.
Pars plana vitrectomy was performed on 10 eyes in the standard manner. No perioperative or postoperative complications were observed. After the PPV, IOP was stable and none of the tested children needed glaucoma surgery. Nevertheless, one eye displayed an IOP lower than 10 Torr, measured by applanation tonometry.
Thereafter, 2 children who had undergone PPV in 1 eye were treated with systemic immunosuppressants (nos. 1 and 4) for a recurrent episode of IU in the other, nonvitrectomized eye.
Three years after PPV on average, 5 eyes were subsequently operated on for posterior subcapsular cataracts (1 eye underwent a combined lensectomy-vitrectomy). Seven eyes treated with PPV showed relapse of inflammation (Tab. III). Five eyes were treated with local corticosteroids or with cryopexy. Because of the relapse of IU in the left eye of a 7-year-old boy (no. 6), 1 year after PPV, we decided to perform an intravitreal injection of 4 mg of Triam. Furthermore, one of the patients we followed up (no. 4) developed a recurrence of CME in the right eye 8 years after PPV (Fig. 1A) . In this case, we applied intravitreal dexamethasone implant (Ozurdex), which improved VA from 0.05 to 0.1 and central retinal thickness from 588 μm to 277 μm (Fig. 1B) . Because of continuing inflammation in the periphery, however, we performed a second peripheral cryopexy of the retina. Table III summarizes treatment after PPV and Figure 2 shows OCT findings after surgery.
An average preoperative VA of 0.32 improved to an average postoperative VA of 0.8. Improvement of VA after PPV is shown in Table IV .
Discussion
Intermediate uveitis accounts for 1.8%-29% of uveitis cases seen in the pediatric age group (7) . In 2004, the Standardization of Uveitis Nomenclature Working Group designated IU as a uveitis where the vitreous is the major site of inflammation.
Peripheral vascular sheathing, neovessels, and macular edema may be present, but are not diagnostic criteria (8) .
In our study, IU was complicated by CME in most cases, and in almost half of treated eyes we also diagnosed peripheral retinal neovessels. The formation of neovessels in the peripheral retina or the papilla is another typical feature of pediatric uveitis (9) . Although the incidence of neovessels is considered to be 4 times greater in children than in adults, we saw it in 4 out of 10 eyes, but no vitreous hemorrhage was noted. The explanation could be the radical treatment management of pediatric uveitis in our study, in which cryotherapy was performed in 9 out of 10 eyes before PPV and PPV was timed rapidly after treatment failure.
Conversely, a hyperemic and swollen optic nerve, more common in childhood uveitic eyes, was present only in one of our patients, although it was chronic recurrent inflammation in most cases. Children are more likely than adults to develop low IOP as well as hypotony in the setting of uveitis (10) . One potential explanation of fluctuation in IOP is the greater severity of uveitis presenting early in life, with possible adverse effects on the development of the ciliary body or outflow pathways. Both fluctuation in IOP and uveitis activity may lead to a higher incidence of swollen optic nerves in children than in adults.
The mean age at onset appears to have 2 peaks: 5-15 years and 15-35 years. The mean age at uveitic onset in our 6 tested children was 8.3 years, with no sex predilection, which is in accordance with the supplied demographic data. The clinical course of IU is variable. The most common cases of IU (approximately 60%) exhibit chronic progressive disease, while 30% experience chronic exacerbation and only 10% of patients have a mild transient form (11) . A similar distribution of the clinical course of IU was noted in our group of children.
We found a significantly reduced relapse rate of chronic uveitis in the long postoperative period of 10 years on average, compared to the preoperative time, and a trend towards reduced systemic corticosteroid demand.
These findings compare well with several studies pertaining to vitrectomy in pediatric uveitis, which have found a reduction in the recurrence rate and the severity of inflammation with a subsequent reduction of the immunosuppressive need in the postoperative course (2-6). A possible explanation for these results could be the restoration of immunologic homeostasis by the mechanical removal of the vitreous body with captured autoreactive T cells and proinflammatory cytokines during PPV (12, 13) . The vitreous humor has a gelatinous consistency in infancy due to electrical changes that hold apart collagen fibers of the vitreous. With inflammation, these charges tend to reduce, and the fibers may collapse and clump together. These findings were found by our pathologic examination, which confirmed astrocytic and lymphocyte proliferation with epithelioid and giant cells. It is presumed that altered vitreous is a possible antigen. The replacement of the vitreous with aqueous humor during PPV reduced recurrences of IU, as we confirmed in our study. Because the exact cause of the overcoming of the bloodretina barrier by activated lymphocytes is unknown, the need for systemic steroids and immunosuppressive treatment was seen after PPV. The primary indication for surgery was CME when systemic steroid treatment had been shown to be ineffective. Our study shows that vitrectomy with removal of pathologic vitreoretinal adhesions at the macula and surgical detachment of the posterior hyaloid has a beneficial effect on CME and VA. The edematous macula is the firmest area of vitreoretinal adhesion. It is notable that we were able to achieve a subtotal removal of vitreous cortex in all 10 eyes. The remaining inflammation-altered vitreous tends to form a macular edema again and could initialize epiretinal membrane formation and retinal traction. In only 2 cases was it necessary to apply triamcinolone acetonide to improve the visibility of the vitreous humor. The remnant vitreous on the retina can be a scaffold of pathologic cells, such as glial and hyalocyte cells, which can eventually cause macular pucker or secondary retinal tractional detachment. To avoid peripheral tangential traction of remaining vitreous, we used indicated cerclage in 5 eyes with severe IU. It is notable that we were able to achieve a subtotal removal of vitreous cortex in all 10 eyes.
An improvement of CME and the course of uveitis after PPV have been noted in other studies (1) (2) (3) (4) (5) (6) , in which no intraoperative complications were seen either. All surgeons have used standard 3-port PPV. The most common postoperative complications in the mentioned studies were a transient elevation of IOP (2-4) and retinal detachment with proliferative vitreoretinopathy that required reoperation in approximately 7% of eyes (1, 5) . There were no serious postoperative complications in our study. Late postoperative recurrences of CME have been described (5, 14) . In one of the follow-up patients, a recurrence of CME developed in the right eye 8 years after PPV. The cause could be chronic activity of IU, which is based on a systemic disease that corresponded to lower IOP measurement in the child.
In order to prevent any injuries to the lens in phakic children, one study (6) recommended using 23-G techniques. Only one eye with a preoperatively clear lens developed a cataract after standard PPV but did not undergo cataract surgery. In this case, a complicated cataract was based on total corticosteroid therapy for relapses of the IU of the second nonvitrectomized eye. These findings are in agreement with the reported frequency of cataract development in other series of children (1) (2) (3) (4) (5) (6) .
In the present study, the increase in VA after PPV could be partly explained by cataract extractions in the postoperative period. Vitrectomy could have accelerated cataract progression, but eliminating intravitreal inflammation thereby reduces the need of corticosteroids.
Improvement in VA was seen in all previous studies (1-6), whose lack was a short follow-up period after PPV. In our study, the mean observation period of 10.3 years confirmed the significant improvement in VA after PPV. Risk factors of PPV in the context of uveitis are that the retina can be very friable and surgery by its nature is proinflammatory. Despite the risks, surgical removal of a diseased vitreous body had long-term beneficial effects on visual function while recurrences of uveitis decreased in our study. Therefore, it is significant that early surgery and early treatment of anatomic findings correlates with a final improvement in VA. Moreover, 3 children who had an operation on one more inflamed eye underwent PPV in the other eye a few years later despite treatment with corticosteroids.
In general, PPV in pediatric uveitis is more difficult to perform than in other eye diseases and in adults. Immediate radical treatment of uveitis with conservative treatment and well-timed PPV soon after failure has a beneficial effect on the course and the complications of chronic uveitis in pediatric and juvenile patients. The most important effects are reduction of CME, reduced relapse rate of IU uveitis, and improvement of VA after PPV. We propose PPV as a surgical treatment option in all cases where immunosuppressive medication fails to improve visual function and to resolve inflammatory activity. Further studies with more pediatric patients and a controlled design are mandatory to investigate the effect of PPV in pediatric uveitis patients.
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